BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24236632)

  • 41. Lung function and respiratory symptoms related to changes in smoking habits in asbestos-exposed subjects.
    Waage HP; Vatten LJ; Opedal E; Hilt B
    J Occup Environ Med; 1996 Feb; 38(2):178-83. PubMed ID: 8673522
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population.
    Tashkin DP; Clark VA; Coulson AH; Simmons M; Bourque LB; Reems C; Detels R; Sayre JW; Rokaw SN
    Am Rev Respir Dis; 1984 Nov; 130(5):707-15. PubMed ID: 6497153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronological change of serum carcinoembryonic antigen (CEA) concentrations and pulmonary function data after cessation of smoking in subjects with smoking-associated CEA abnormality.
    Kashiwabara K; Nakamura H; Yokoi T
    Clin Chim Acta; 2001 Jan; 303(1-2):25-32. PubMed ID: 11163019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in breathomics from a 1-year randomized smoking cessation trial of electronic cigarettes.
    Campagna D; Cibella F; Caponnetto P; Amaradio MD; Caruso M; Morjaria JB; Malerba M; Polosa R
    Eur J Clin Invest; 2016 Aug; 46(8):698-706. PubMed ID: 27322745
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of CT screening on smoking habits at 1-year follow-up in the Danish Lung Cancer Screening Trial (DLCST).
    Ashraf H; Tønnesen P; Holst Pedersen J; Dirksen A; Thorsen H; Døssing M
    Thorax; 2009 May; 64(5):388-92. PubMed ID: 19052048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of COPD-6 Vitalograph in Primary Care as tool for smoking cessation].
    Antón-García F; Pruteanu DF; Correcher-Salvador E
    Semergen; 2016 Mar; 42(2):75-80. PubMed ID: 25817853
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study.
    Sansores RH; Ramírez-Venegas A; Arellano-Rocha R; Noé-Díaz V; García-Gómez L; Pérez Bautista O; Velázquez Uncal M
    Ther Adv Respir Dis; 2016 Oct; 10(5):383-90. PubMed ID: 27352612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of smoking cessation on pulmonary function: a 30-month follow-up of two smoking cessation clinics.
    Buist AS; Nagy JM; Sexton GJ
    Am Rev Respir Dis; 1979 Oct; 120(4):953-7. PubMed ID: 507517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes.
    Cibella F; Campagna D; Caponnetto P; Amaradio MD; Caruso M; Russo C; Cockcroft DW; Polosa R
    Clin Sci (Lond); 2016 Nov; 130(21):1929-37. PubMed ID: 27543458
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function.
    Jensen EJ; Pedersen B; Frederiksen R; Dahl R
    Thorax; 1998 Sep; 53(9):784-9. PubMed ID: 10319062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of an intensive pharmacist-managed telephone clinic with standard of care for tobacco cessation in a veteran population.
    Chen T; Kazerooni R; Vannort EM; Nguyen K; Nguyen S; Harris J; Bounthavong M
    Health Promot Pract; 2014 Jul; 15(4):512-20. PubMed ID: 24231631
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease in lung recoil pressure after cessation of smoking.
    Zamel N; Leroux M; Ramcharan V
    Am Rev Respir Dis; 1979 Feb; 119(2):205-11. PubMed ID: 434593
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rates of decline in lung function among subjects who restart cigarette smoking.
    Sherrill DL; Enright P; Cline M; Burrows B; Lebowitz MD
    Chest; 1996 Apr; 109(4):1001-5. PubMed ID: 8635322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Detecting airflow obstruction in smoking cessation trials: a rationale for routine spirometry.
    Bohadana A; Nilsson F; Martinet Y
    Chest; 2005 Sep; 128(3):1252-7. PubMed ID: 16162715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myeloperoxidase as a marker of increasing systemic inflammation in smokers without severe airway symptoms.
    Andelid K; Bake B; Rak S; Lindén A; Rosengren A; Ekberg-Jansson A
    Respir Med; 2007 May; 101(5):888-95. PubMed ID: 17098408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term effects of smoking cessation: benefit or penalty?
    Young RC; Rachal RE; Carr PG
    J Natl Med Assoc; 1989 Jun; 81(6):685-90. PubMed ID: 2746691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Evaluation of walk-in lung function service for smokers in Copenhagen--a 1-year study].
    Backer V; Bolton S; Ehlers HD; Thomsen S; Pedersen L; Porsbjerg C; Lund T; Harmsen L; Fuglsang C
    Ugeskr Laeger; 2008 Aug; 170(35):2682-5. PubMed ID: 18761857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation.
    Willemse BW; Postma DS; Timens W; ten Hacken NH
    Eur Respir J; 2004 Mar; 23(3):464-76. PubMed ID: 15065840
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Smoking cessation, decline in pulmonary function and total mortality: a 30 year follow up study among the Finnish cohorts of the Seven Countries Study.
    Pelkonen M; Notkola IL; Tukiainen H; Tervahauta M; Tuomilehto J; Nissinen A
    Thorax; 2001 Sep; 56(9):703-7. PubMed ID: 11514691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters.
    Eberly LE; Ockene J; Sherwin R; Yang L; Kuller L;
    Int J Epidemiol; 2003 Aug; 32(4):592-9. PubMed ID: 12913035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.